KRAS and lung carcinoma: Ntrk1 has been proven to induce the upregulation of PD-L1 in mesenchymal Kras/p53 mutant lung cancer cells by stimulating Jak/Stat signaling, leading to the exhaustion of CD8+ T cells within the TME (119).